256 related articles for article (PubMed ID: 36914786)
1. Extracellular urinary microRNAs as non-invasive biomarkers of endometrial and ovarian cancer.
Hanžek A; Siatka C; Duc AE
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7981-7993. PubMed ID: 36914786
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study.
Záveský L; Jandáková E; Turyna R; Langmeierová L; Weinberger V; Záveská Drábková L; Hůlková M; Hořínek A; Dušková D; Feyereisl J; Minář L; Kohoutová M
Pathol Oncol Res; 2015 Sep; 21(4):1027-35. PubMed ID: 25827090
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA and gynecologic cancers.
Kanekura K; Nishi H; Isaka K; Kuroda M
J Obstet Gynaecol Res; 2016 Jun; 42(6):612-7. PubMed ID: 27098274
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potential serum and urine-based microRNA as minimally-invasive biomarkers for breast and gynecological cancer.
Ritter A; Hirschfeld M; Berner K; Jaeger M; Grundner-Culemann F; Schlosser P; Asberger J; Weiss D; Noethling C; Mayer S; Erbes T
Cancer Biomark; 2020; 27(2):225-242. PubMed ID: 32083575
[TBL] [Abstract][Full Text] [Related]
5. Role of microRNAs in gynecological pathology.
Gilabert-Estelles J; Braza-Boils A; Ramon LA; Zorio E; Medina P; Espana F; Estelles A
Curr Med Chem; 2012; 19(15):2406-13. PubMed ID: 22455593
[TBL] [Abstract][Full Text] [Related]
6. Supernatant versus exosomal urinary microRNAs. Two fractions with different outcomes in gynaecological cancers.
Zavesky L; Jandakova E; Turyna R; Langmeierova L; Weinberger V; Minar L
Neoplasma; 2016; 63(1):121-32. PubMed ID: 26639242
[TBL] [Abstract][Full Text] [Related]
7. Association of microRNA-200c expression levels with clinicopathological factors and prognosis in endometrioid endometrial cancer.
Wilczynski M; Danielska J; Domanska-Senderowska D; Dzieniecka M; Szymanska B; Malinowski A
Acta Obstet Gynecol Scand; 2018 May; 97(5):560-569. PubMed ID: 29355888
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case-control study.
Berner K; Hirschfeld M; Weiß D; Rücker G; Asberger J; Ritter A; Nöthling C; Jäger M; Juhasz-Böss I; Erbes T
Arch Gynecol Obstet; 2022 Jul; 306(1):151-163. PubMed ID: 34889994
[TBL] [Abstract][Full Text] [Related]
9. Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview.
Staicu CE; Predescu DV; Rusu CM; Radu BM; Cretoiu D; Suciu N; Crețoiu SM; Voinea SC
Cells; 2020 Jan; 9(1):. PubMed ID: 31936634
[TBL] [Abstract][Full Text] [Related]
10. Identification of Endometrial Cancer-Specific microRNA Biomarkers in Endometrial Fluid.
Yang J; Barkley JE; Bhattarai B; Firouzi K; Monk BJ; Coonrod DV; Zenhausern F
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240034
[TBL] [Abstract][Full Text] [Related]
11. Detection of MCM5 as a novel non-invasive aid for the diagnosis of endometrial and ovarian tumours.
Stockley J; Akhand R; Kennedy A; Nyberg C; Crosbie EJ; Edmondson RJ
BMC Cancer; 2020 Oct; 20(1):1000. PubMed ID: 33059604
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic potential of differentially regulated microRNAs among endometriosis, endometrioid ovarian cancer, and endometrial cancer.
Kumari P; Sharma I; Saha SC; Srinivasan R; Minhas P
J Cancer Res Ther; 2021; 17(4):1003-1011. PubMed ID: 34528556
[TBL] [Abstract][Full Text] [Related]
13. Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy.
Traver S; Assou S; Scalici E; Haouzi D; Al-Edani T; Belloc S; Hamamah S
Hum Reprod Update; 2014; 20(6):905-23. PubMed ID: 24973359
[TBL] [Abstract][Full Text] [Related]
14. Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in vitro.
Hirschfeld M; Ge I; Rücker G; Waldschmidt J; Mayer S; Jäger M; Voigt M; Kammerer B; Nöthling C; Berner K; Weiss D; Asberger J; Erbes T
Mol Med Rep; 2020 Nov; 22(5):4048-4060. PubMed ID: 33000259
[TBL] [Abstract][Full Text] [Related]
15. Expression of microRNA-145, OCT4, and SOX2 in double primary endometrioid endometrial and ovarian carcinomas.
Zhang R; Jiao J; Chu H; Yang H; Wang L; Gao N
Histol Histopathol; 2018 Aug; 33(8):859-870. PubMed ID: 29569698
[TBL] [Abstract][Full Text] [Related]
16. MiR-548c impairs migration and invasion of endometrial and ovarian cancer cells via downregulation of Twist.
Sun X; Cui M; Zhang A; Tong L; Wang K; Li K; Wang X; Sun Z; Zhang H
J Exp Clin Cancer Res; 2016 Jan; 35():10. PubMed ID: 26762267
[TBL] [Abstract][Full Text] [Related]
17. Strategies for Lynch syndrome identification in selected and unselected gynecological cancers.
Carnevali I; Sahnane N; Chiaravalli AM; Di Lauro E; Facco C; Facchi S; Casarin J; Ghezzi F; Sessa F; Tibiletti MG
Eur J Cancer Prev; 2022 Jul; 31(4):369-376. PubMed ID: 34519692
[TBL] [Abstract][Full Text] [Related]
18. A Non-invasive Liquid Biopsy Screening of Urine-Derived Exosomes for miRNAs as Biomarkers in Endometrial Cancer Patients.
Srivastava A; Moxley K; Ruskin R; Dhanasekaran DN; Zhao YD; Ramesh R
AAPS J; 2018 Jul; 20(5):82. PubMed ID: 29987691
[TBL] [Abstract][Full Text] [Related]
19. Beyond circulating microRNA biomarkers: Urinary microRNAs in ovarian and breast cancer.
Gasparri ML; Casorelli A; Bardhi E; Besharat AR; Savone D; Ruscito I; Farooqi AA; Papadia A; Mueller MD; Ferretti E; Benedetti Panici P
Tumour Biol; 2017 May; 39(5):1010428317695525. PubMed ID: 28459207
[TBL] [Abstract][Full Text] [Related]
20. A bioinformatics analysis of the clinicopathological and prognostic significance of
Zheng HC; Ren DH; Zhang CY; Chen Y; Zhang L
J Obstet Gynaecol; 2023 Dec; 43(1):2216280. PubMed ID: 37227120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
